Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease

NCT01421719 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease
Neurogenic Bladder
Urinary Incontinence
Clostridium Botulinum Toxin Adverse Reaction

Interventions

DRUG: Cystoscopic injection of Botox into the urinary bladder

Sponsor

Stanford University

Collaborators

[object Object]